Literature DB >> 12431156

Percutaneous stent-graft repair of mycotic common femoral artery aneurysm.

Kihwan Kwon1, Donghoon Choi, Seung-Hyuk Choi, Bon Kwon Koo, Young-Guk Ko, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho.   

Abstract

PURPOSE: To report successful percutaneous repair of a peripheral mycotic aneurysm as a bridge to standard surgical therapy. CASE REPORT: An aneurysm of the left common femoral artery was diagnosed in a 43-year-old man with subacute infective endocarditis. A Jostent stent-graft was percutaneously deployed to exclude the mycotic lesion. Computed tomography at 8 months after the procedure documented aneurysm regression and stent-graft patency without evidence of infection. Arteriography at 18 months has confirmed continued stent-graft patency and the patient remains asymptomatic.
CONCLUSIONS: The standard management of mycotic aneurysms is usually by surgical resection and repair. However, this case suggests that percutaneous stent-graft implantation may be an option for the treatment of mycotic aneurysms.

Entities:  

Mesh:

Year:  2002        PMID: 12431156     DOI: 10.1177/152660280200900522

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  3 in total

1.  Stent graft exclusion of a mycotic profunda femoris artery pseudoaneurysm with 2-year follow-up.

Authors:  Ahmed Aboubakr-Esedik Bakr; James Harding; Asif Mahmood; Devaraj Srinivasamurthy
Journal:  BMJ Case Rep       Date:  2019-06-02

2.  Ruptured mycotic common femoral artery pseudoaneurysm: fatal pulmonary embolism after emergency stent-grafting in a drug abuser.

Authors:  Christos D Karkos; Thomas E Kalogirou; Ioakeim T Giagtzidis; Konstantinos O Papazoglou
Journal:  Tex Heart Inst J       Date:  2014-12-01

3.  Management options in the treatment of femoral pseudoaneurysms secondary to intravenous drug abuse: A case series.

Authors:  James Rammell; Nisheeth Kansal; Vish Bhattacharya
Journal:  Int J Surg Case Rep       Date:  2017-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.